Comorbidities | Survivors n = 317 (56.4%) | Non-Survivors n = 245 (43.6%) | Total (n = 563) | p-value (OR; CI 95%) |
---|---|---|---|---|
Hypertension | 112 (53.6%) | 97 (46.4%) | 209 (21.1%) | 0.002* (1.65; 1.19-2.30) |
Diabetes | 83 (51.9%) | 77 (48.1%) | 160 (16.2%) | 0.002* (1.73; 1.21-2.47) |
Moderate-to-severe renal disease | 43 (41%) | 62 (59%) | 105 (10.6%) | < 0.005* (2.77; 1.81-4.23) |
Congestive heart failure | 48 (52.7%) | 43 (47.3%) | 91 (9.2%) | 0.046* (1.56; 1.0-2.43) |
Cerebrovascular disease | 44 (48.9%) | 46 (51.1%) | 90 (9.1%) | 0.005* (1.86; 1.19-2.91) |
Tumour (benign or malignant) | 56 (62.9%) | 33 (37.1%) | 89 (9.0%) | 0.885 |
Prior myocardial infarction | 41 (70.7%) | 17 (29.3%) | 58 (5.9%) | 0.166 |
Peripheral vascular disease | 24 (57.1%) | 18 (42.9%) | 42 (4.2%) | 0.484 |
Chronic pulmonary disease | 12 (42.9%) | 16 (57.1%) | 28 (2.8%) | 0.031* (2.27; 1.05-4.87) |
Diabetes with chronic complications | 6 (23.1%) | 20 (76.9%) | 26 (2.6) | < 0.005* (5.83; 2.31-14.73) |
Moderate or severe liver disease | 10 (43.5%) | 13 (56.5%) | 23 (2.3%) | 0.06 |
Mild liver disease | 11 (53.4%) | 10 (47.6%) | 21 (2.1%) | 0.345 |
Dementia | 5 (38.5%) | 8 (61.5%) | 13 (1.3%) | 0.075 |
Non-CVD neurologic disease | 7 (53.8%) | 6 (46.2%) | 13 (1.3%) | 0.529 |
Metastatic solid tumor | 6 (50%) | 6 (50%) | 12 (1.2%) | 0.378 |
Peptic ulcer disease | 3 (50%) | 3 (50%) | 6 (0.6%) | 0.535 |
Rheumatologic disease | 0 | 2 (100%) | 2 (0.2%) | 0.069 |
Leukemia | 0 | 1 (100%) | 1 (0.1%) | 0.199 |
Lymphoma | 0 | 0 | 0 (0.0%) | n/a |
Acquired immunodeficiency syndrome (AIDS) | 0 | 0 | 0 (0.0%) | n/a |